PR Newswire Asia's news > Medical Equipment

 < Previous page   |   Title only   |   Print    Next page > 
     
SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients
TOKYO and BOSTON , Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), ...
2026-09-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam
HANOI, Vietnam , Sept. 25, 2026 /PRNewswire/ -- Greenfield Dental has recorded a significant surge in international patient volume with over 300% growth since 2025, reflecting Vietnam's emergence as ...
2026-09-25T    Health Care/Hospital   Medical Equipment 
From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026
ZEISS Medical Technology advances its  ZEISS Retina Workflow  with digital and surgical enhancements, and new imaging technologies, including: ...
2026-09-24T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Carestream Healthcare International Launches STARVIEW Digital Radiography System
SHANGHAI , Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of the CARESTREAM STARVIEW Digital Radiography System , a focused, floor-mounted DR room designed ...
2026-09-24T    Computer Hardware   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
After the Weight Comes Off: Treating GLP-1-Related Skin Laxity with Sofwave
SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Across cosmetic and dermatology clinics, a new patient profile is becoming increasingly familiar. Someone who has lost a significant amount of weight on a  ...
2026-09-24T    Cosmetics & Personal Care   Health Care/Hospital   Medical Equipment 
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026
104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ...
2026-09-23T    Health Care/Hospital   Household/Consumer/Cosmetics   Medical Equipment   Medical/Pharmaceuticals 
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT
HONG KONG , Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Leedon Technology Expands Healthcare Technical Capabilities with Authorised IMT Analytics Service Centre in Singapore
The new service centre builds on more than two decades of healthcare industry experience, expanding local calibration and technical support for medical gas flow devices and analysers ...
2026-09-23T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.